Elevance Health, Inc. has shown remarkable dividend growth in the past decade, exceeding revenue and EPS expectations for the first quarter. Elevance's balance sheet remains A-rated, and shares of ...

Elevance Health (ELV) came out with quarterly earnings of $10.12 per share, beating the Zacks Consensus Estimate of $9.99 per share. This compares to earnings of $9.04 per share a year ago.

Elevance Health's (ELV) second-quarter results are likely to be aided by improved product revenues, commercial fee-based membership growth, and lower expenses.

The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector's strength is driven by ...

While it's never a bad time to look for healthcare stocks to buy, the privatization of Medicare has created some very prosperous businesses. As a result, it's not necessarily great for consumers.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Elevance Health (ELV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Shares of Elevance Health (ELV) rose to their highest level since late 2022 on Thursday as the health insurance provider posted better-than-expected results and raised its guidance amid lower costs.

Elevance Health Inc.'s stock rose 4.7% on Thursday, after the health insurer posted better-than-expected profit for the first quarter and raised a full-year guidance metric, offsetting a revenue sh...

Elevance Health (ELV) has a leftover capacity of around $3.6 billion under its share buyback authorization.

While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics...